Baylor IDDRC focuses on understanding and treating 17p- syndrome
Official title: Baylor College of Medicine Intellectual and Developmental Disabilities Research Center
Funded at Baylor College of Medicine · NIH-11532977 · Data updated 2026-11-12
A Baylor College of Medicine research center is expanding its work to understand the causes of IDD, including 17p- syndrome, and to develop therapies that could help kids and adults with these conditions.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Baylor College of Medicine NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project start | August 25, 2026 |
| Project end | May 31, 2027 |
| Funding year | 2026 |
| Award (this year) | $1,156,763 |
| NIH project number | 3P50HD103555-05S2 |
| Project ID | NIH-11532977 on NIH RePORTER |
Who could benefit from this research
✓Could help
Individuals with 17p- syndrome or other IDD conditions, across childhood to adulthood, who may benefit from translational research and future therapies.
✕Less likely to help
Patients not directly linked to IDD research or those not participating in translational activities may not experience direct benefits.
What this research studies
This grant supports Baylor’s Intellectual and Developmental Disabilities Research Center in continuing its basic science, translational, and clinical efforts to uncover causes of IDD such as 17p- syndrome and move toward therapies. It provides core facilities that study molecules, cells, circuits, and whole organisms, with a Clinical Translational Core to bridge lab findings to patient care. The goal is to accelerate discovery and translate insights into better diagnosis and treatment options for individuals with IDD across the lifespan.
Why it matters
Potential benefit: If successful, findings could lead to earlier diagnosis, better therapies, and improved quality of life for people with IDD, including those with 17p- syndrome.
How similar studies have gone: Previous IDDRCs have successfully linked basic discoveries to translational approaches, showing promise for IDD therapies.
Where this research is happening
-
Baylor College of Medicine
Houston, United States Active
Researchers
- Principal investigator: Nagamani, Sandesh Chakravarthy Sreenath — Baylor College of Medicine
- Study coordinator: Nagamani, Sandesh Chakravarthy Sreenath
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.